iCAA Association

The International CAA Association (ICAAA) was founded in 2014 with the goal of improving scientific understanding, diagnosis, and treatment of cerebral amyloid angiopathy (CAA). The ICAAA is comprised of leading clinicians and scientists in the CAA field drawn from medical centers and universities around the world. The ICAAA organizes bi-annual scientific meetings of the international CAA community, collaborative research projects, and consensus guidelines, all aimed at improving the condition of individuals suffering from this increasingly recognized disease of the brainโ€™s small blood vessels.

Board Members:

Steven M. Greenberg,
MD PhD - Chairman

Massachusetts General Hospital / Harvard Medical School, Boston, MA, USA

Mark A. van Buchem,
MD PhD - Secretary

Leiden University Medical Center, the Netherlands

Charlotte Cordonnier,
MD PhD - Treasurer

Lille University, France

Eric E. Smith,
MD

University of Calgary, Canada

Susanne J. van Veluw,
PhD

Massachusetts General Hospital / Harvard Medical School, Boston, MA, USA
Leiden University Medical Center, the Netherlands

Julie A. Schneider,
MD MS

Rush University, Chicago, Il, USA

Marcel M. Verbeek,
PhD

Radboud University, Nijmegen, the Netherlands

Office:

Elmi van Beelen

Sandra Fens

Email: office@caaforum.org